Since hyperinsulinemia is considered a potential contributor to DCM, it is noteworthy that STZ injection, which induces pancreatic damage, led to a significant reduction in insulin levels, resulting in hypoinsulinemia in this model. This evidence concerns the gene INS and hyperinsulinism.